• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

News

September 8, 2016

VIDEOS: European Society of Cardiology Congress 2016

News Sep 8, 2016 VIDEOS: European Society of Cardiology Congress 2016 In a series of videos, Dr. Javed Butler shares details from his ESC Congress Hot Line presentation and news and views about the conference. VIEW VIDEOS HERE

Read More

Media Coverage,  News

September 7, 2016

CardioCell LLC Retains Objective Capital Partners

News Sep 7, 2016 CardioCell LLC Retains Objective Capital Partners San Diego biotech CardioCell LLC has retained Objective Capital Partners, an investment bank and mergers and acquisitions advisory firm, to help the company “manage growth,” the company said in a

Read More

Media Coverage,  News

September 7, 2016

Objective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies

News Sep 7, 2016 Objective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies SAN DIEGO – Sept. 7, 2016 – Objective Capital Partners, a leading middle market investment bank and mergers and acquisition (M&A) advisory firm focused on transactions for

Read More

News,  Press Releases

September 2, 2016

ESC: IV Stem Cells for Heart Failure: ‘A Lot More to Learn’

News Sep 2, 2016 ESC: IV Stem Cells for Heart Failure: 'A Lot More to Learn' Intravenous infusion of mesenchymal stem cells failed to improve cardiac function in heart failure patients but the treatment did appear to give patients some benefits such as improvement in physical

Read More

Media Coverage,  News

August 30, 2016

CardioCell reports Phase IIa heart failure data

News Aug 30, 2016 CardioCell reports Phase IIa heart failure data Data presented at the European Society of Cardiology meeting in Rome showed that a single intravenous administration of ischemic-tolerant mesenchymal stem cells (itMSCs) from CardioCell LLC met the primary safety

Read More

Media Coverage,  News

August 30, 2016

VIDEO – ESC 2016: beneficial effects of allogeneic mesenchymal stem cells in HF patients

News Aug 30, 2016 VIDEO - ESC 2016: beneficial effects of allogeneic mesenchymal stem cells in HF patients Javed Butler Describes the main findings from the Phase IIa CardioCell's Heart Failure study on the safety and efficacy of intravenous infusion of ischemia-tolerant allogeneic

Read More

Media Coverage,  News

August 30, 2016

IV Administration of Stem Cells Viable and More Practical Than Direct Cardiac Implantation

News Aug 30, 2016 IV Administration of Stem Cells Viable and More Practical Than Direct Cardiac Implantation MedicalResearch.com Interview with: Javed Butler, M.D., MPH, FACC, FAHA, Chief of the Cardiology Division and Co-Director of the Heart Institute at Stony Brook

Read More

Media Coverage,  News

August 30, 2016

CardioCell announces positive results from phase IIa study evaluating IV administration of stem cells for chronic HF indications

News Aug 30, 2016 CardioCell announces positive results from phase IIa study evaluating IV administration of stem cells for chronic HF indications CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announced data from its

Read More

Media Coverage,  News

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Page 7
  • Next Page »

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in